Skip to main content
Istanbul Stem Cells logo

Stabilize first, rehabilitate, then consider research-grade support

Stem cell therapy for traumatic brain injury in Istanbul, Turkey

Our Istanbul team sequences TBI stabilization and rehabilitation before offering an honestly explained, closely supervised cell therapy option.

Condition-specific editorial anatomy. Explanatory labels remain in accessible text.

Evidence position

What is known, what is investigational, and what is not demonstrated

Care foundation

Rehabilitation-first, research-aware support

Acute instability, bleeding, raised intracranial pressure, seizures, or evolving deficits always take priority over elective travel.

Research boundary

Timing changes everything

Mild, moderate, and severe TBI have different trajectories, and we plan around your specific injury pattern.

Claim check

Routes are not interchangeable

Results vary between patients and stem cell therapy is not a guaranteed cure — we measure recovery in function and safety, not a scan alone.

Direct answer

What the current evidence says

We don't promise brain regeneration or a set level of recovery after traumatic brain injury — no program honestly can. What we offer is a phase-appropriate plan: acute and neurocritical needs come first, rehabilitation is protected throughout, and where a small, carefully monitored cell therapy protocol may add supportive value, our physicians explain exactly what the early research does and doesn't show. Request your free medical evaluation to review your case.

Clinical map

Start with the diagnosis, stage, and treatment context

We don't claim any generic MSC, exosome, or infusion protocol delivers predictable neurologic recovery after TBI.

Established care comes first

  • Neurorehabilitation: We coordinate PT, OT, speech-language, neuropsychology, and vocational support around your specific deficits.
  • Complication management: We help address seizures, spasticity, pain, sleep, mood, and nutrition throughout your program.
  • Goal-based follow-up: We set attainable participation and independence goals with standardized reassessment over time.
  1. 01

    Acute injury

    Stabilization, imaging, intracranial management, and seizure care are time-critical and come before anything else.

  2. 02

    Post-acute rehabilitation

    Mobility, speech, swallowing, cognition, vision, and behavior goals are coordinated across your recovery.

  3. 03

    Persistent symptoms

    Headache, dizziness, fatigue, mood, sleep, and pain each get individual assessment and treatment.

Evidence ledger

Read the actual study, including the result that did not change

Each row keeps product identity, route, endpoint, and limitation together so one trial cannot become a generic treatment claim.

  1. 01

    Six-patient Wharton's jelly MSC phase 1 TBI study

    Open source
    Product
    Wharton's jelly-derived mesenchymal stromal cells
    Route
    Six combined intrathecal, intramuscular, and intravenous administrations
    Design
    Single-arm phase 1 study with pre-intervention and post-intervention comparisons
    Finding
    The authors reported transient early adverse effects and within-participant functional score changes during one-year follow-up.
    Limitation
    Six young adults, no comparator, combined routes, repeated dosing, and natural recovery or rehabilitation confounding prevent efficacy inference or route attribution.

Product and route

A mechanism is not a clinical outcome

  1. 01

    Timing changes everything

    An acute neurocritical intervention is not the same as a chronic outpatient infusion, even when both use the term MSC — we explain the difference plainly.

    BoundaryEvidence applies only to the studied product, population, dose, route, comparator, and endpoint.

  2. 02

    Routes are not interchangeable

    IV, intrathecal, and local delivery carry different procedural risks, and we won't let one route's results stand in for another's.

    BoundaryEvidence applies only to the studied product, population, dose, route, comparator, and endpoint.

Man completing hand rehabilitation beside profile brain anatomy with a focal injury area and a magnified axonal network

Outcomes before travel

Decide what meaningful change would look like

A baseline and a time point matter more than an isolated testimonial. These measures should be chosen before any intervention.

  1. 01

    Glasgow Outcome Scale Extended

  2. 02

    Functional Independence Measure

  3. 03

    Validated cognitive and behavioral testing

  4. 04

    Mobility, communication, swallowing, and return to roles

  5. 05

    Seizures, hospitalizations, and any adverse events

Specialist review

What a complete Istanbul review needs

Our Istanbul team sequences TBI stabilization and rehabilitation before offering an honestly explained, closely supervised cell therapy option.

Records and baseline

  • Injury date, mechanism, severity, acute imaging, and hospital course
  • Current MRI or CT and neurologic examination
  • Seizure, anticoagulation, shunt, and spasticity history
  • Rehabilitation reports and baseline functional measures
  • Consent capacity, caregiver support, and travel tolerance

Safety and planning checks

  • Acute or medically unstable TBI is not an elective travel scenario, and we'll tell you if that's the case.
  • We never pause rehabilitation or antiseizure treatment for an experimental option.
  • Your Istanbul plan includes accessible transport, caregiver participation, and emergency transfer arrangements.

Transparent planning

Build the medical plan before the package

A quote should follow record review, product disclosure, route rationale, and a written follow-up plan. This page does not invent a universal price.

  • Acute or medically unstable TBI is not an elective travel scenario, and we'll tell you if that's the case.
  • We never pause rehabilitation or antiseizure treatment for an experimental option.
  • Your Istanbul plan includes accessible transport, caregiver participation, and emergency transfer arrangements.
Read the cost and planning guide

Questions the plan must answer

  1. 01

    Timing changes everything: An acute neurocritical intervention is not the same as a chronic outpatient infusion, even when both use the term MSC — we explain the difference plainly.

  2. 02

    Routes are not interchangeable: IV, intrathecal, and local delivery carry different procedural risks, and we won't let one route's results stand in for another's.

FAQ

Questions patients ask before an Istanbul review

We won't claim that. Existing human studies are small and use different products and routes, so we focus on what a well-run, honest supportive program can offer instead.

Request Medical Evaluation

Begin a personalized treatment conversation with our medical team.

Share your case in confidence. Our international coordinators review every enquiry and respond within 24 hours, in your language.